complication would be decisive in the development of liver cancer

complication would be decisive in the development of liver cancer
complication would be decisive in the development of liver cancer

Some pathologies promote the manifestation of chronic diseases if it is not controlled and properly treated

Dra. Marcia Cruz, Executive Director of the Comprehensive Cancer Center

The scarcity of resources that some diseases have can seriously affect those who suffer from them, this is the case of Hepatitis C, a pathogen that requires care from its diagnosis in order to prevent advanced clinical pictures that can chronically affect the patient. patient, therefore, it is important to have each of the scientific, medical and health tools for care in the branch of infectology.

In the recent discussion on Hepatitis C, Dr. Marcia Cruz, Executive Director of the Comprehensive Cancer Center, delves into the relationship of this pathogen with the progression of the disease and the development of cancer cells in the liver.

Related news

Molecular treatments continue to evolve against Hepatitis C on the island

He also explains: “The reason why this virus can cause cancer is because this pathogen causes fibrosis and cirrhosis (…), and it is this condition that causes cells to begin to damage and initiate some mutations inside the liver and the protection capacity is lost and the hepatoma finally develops ”.


Liver-type cancer in contrast with the other typologies occupies a considerable place in the rates of illness, this is how a call for attention is made to prevent this manifestation where the cause tends to be due to hepatitis c infections.

“At a global level, liver cancer occupies the 5th place and is the second cause of death, the therapies that are available today are not totally effective, (…) in Puerto Rico for the woman is the sixth cancer diagnosed and in men ranks fourth, (…) the incidence in men is higher, especially from 40 years of age, ”he says.

Equity to guarantee public health

Cruz highlights that for there to be a service and follow-up to patients suffering from Hepatitis C, there must be equity in access to medical service, in this way, appropriate treatment can be guaranteed and the quality of life of patients is considerably improved, in addition to that there will be a greater control in this epidemiology.

“Having access to medicines for this Hepatitis C disease must be included in the correct medical plan, in order to eliminate Hepatitis C in Puerto Rico and demonstrate that we are a country of equality, (…) no only to have access to treatment, but to make the changes that have to be made in our system, where the patient receives access to these benefits. Access to medicines is equity in health, treatment for Hepatitis C was approved in the US and was available through private medical plans in 2013, it was not until 2019 that patients from Puerto Rico had access to approved treatment, this is something that should be monitored, it is the guarantee, medical is a necessity, “he said.


Although the therapies that Hepatitis C has are focused on preventing possible serious complications in the future, it must be clearly taken into account that avoiding the process of cirrhosis is essential since it is the main cause by which cancer manifests itself.

“The treatment of a patient must be clearly focused on preventing cirrhosis from manifesting because, as mentioned above, it is the number one cause for cancer to occur, this is how full attention should be given to the patient with hepatitis C, since it is the starting point where all the tools must be provided to treat the condition and prevent chronic diagnoses in the future ”, he concluded.

For Latest Updates Follow us on Google News

PREV The Matthew Perry Photographs That Raised Concern
NEXT IRTP: Government Recommends Former Congress Candidate Óscar Eduardo Bravo as New Executive President | POLITICS